P. Clay

Mouse lymphoma thymidine kinase gene mutation assay: Meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment

Martha M. Moore, Masamitsu Honma, Julie Clements et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2006 · 58 citations

Pharmacy, Genetics, Oncology +14

Evaluation of phenobarbital/β-naphthoflavone as an alternative S9-induction regime to Aroclor 1254 in the rat for use in <i>in vitro</i> genotoxicity assays

R.D. Callander, J.M. Mackay, P. Clay et al. · Mutagenesis · 1995 · 41 citations

Pharmacy, Pharmacology, Toxicology +15

Thalidomide: lack of mutagenic activity across phyla and genetic endpoints

J. Ashby, H. Tinwell, R.D. Callander et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 1997 · 36 citations

Pharmacy, Genetics, Toxicology +10

An assessment of the genetic toxicology of antimony trioxide

B.M. Elliott, J.M. Mackay, P. Clay et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 1998 · 28 citations

Pharmacy, Genetics, Toxicology +7

Assessment of the genotoxicity of trichloroethylene and its metabolite, S-(1,2-dichlorovinyl)-L-cysteine (DCVC), in the comet assay in rat kidney

P. Clay · Mutagenesis · 2007 · 20 citations · Full text

Pharmacy, Toxicology, Biochemical Toxicology +16